Testing effectiveness (Phase 2)Study completedNCT02847598
What this trial is testing
Study to Evaluate BIIB059 (Litifilimab) in Cutaneous Lupus Erythematosus (CLE) With or Without Systemic Lupus Erythematosus (SLE)
Who this might be right for
Systemic Lupus ErythematosusActive Cutaneous Lupus Erythematosus
Biogen 264